-
-
W417246-500mgcytotoxic agent.
-
W417246-50mgcytotoxic agent.
-
W418103-250mgInhibitor for BCR-ABL Kinase.
-
W418103-25mgInhibitor for BCR-ABL Kinase.
-
W418103-50mgInhibitor for BCR-ABL Kinase.
-
W418103-5mgInhibitor for BCR-ABL Kinase.
-
W417287-100mgmodulating CFTR activity: restore E-cadherin expression in the SW620 colon adenocarcinoma cell line: anti-restenosis activity and accelerates reendothelization: activator of Wnt/b-catenin signal transmission:.
-
W417287-10mgmodulating CFTR activity: restore E-cadherin expression in the SW620 colon adenocarcinoma cell line: anti-restenosis activity and accelerates reendothelization: activator of Wnt/b-catenin signal transmission:.
-
W417287-250mgmodulating CFTR activity: restore E-cadherin expression in the SW620 colon adenocarcinoma cell line: anti-restenosis activity and accelerates reendothelization: activator of Wnt/b-catenin signal transmission:.
-
W417287-25mgmodulating CFTR activity: restore E-cadherin expression in the SW620 colon adenocarcinoma cell line: anti-restenosis activity and accelerates reendothelization: activator of Wnt/b-catenin signal transmission:.
-
W417287-50mgmodulating CFTR activity: restore E-cadherin expression in the SW620 colon adenocarcinoma cell line: anti-restenosis activity and accelerates reendothelization: activator of Wnt/b-catenin signal transmission:.